Smoking and biliary tract cancers in a cohort of US veterans. by Chow, W. H. et al.
Bridsh Journal of Cancer (1995) 72, 1556-1558
©) 1995 Stockton Press All rights reserved 0007-0920/95 $12.00
SHORT COMMUNICATION
Smoking and biliary tract cancers in a cohort of US veterans
W-H Chow, JK McLaughlin*, Z Hrubec and JF Fraumeni Jr
Epidemiology and Biostatistics Program, Division ofCancer Etiology, National Cancer Institute, Bethesda, MD, USA.
Summary Except for gallstones, the risk factors for cancers of the biliary tract (CBTs) are poorly understood.
Recent case-control studies have suggested cigarette smoking as a potential risk factor. In a cohort study of
nearly 250 000 US veterans whose mortality was followed for up to 26 years, we evaluated the risk of CBT
associated with tobacco use. Relative risks (RRs) and corresponding 95% confidence intervals (CIs) were
calculated. A total of 303 CBT deaths were observed during the follow-up period. Compared with those who
had never used any tobacco, current cigarette smokers at entry to the cohort had a 50% excess risk of CBT
(RR= 1.5, CI = 1.1-2.0). A nearly 2-fold risk was observed among those who smoked more than 20
cigarettes per day and among those who started smoking under age 20. Non-significant increases in risk
occurred among smokers of other forms of tobacco. This cohort study is consistent with reports that smoking
is a risk factor for CBT, but further studies are needed to clarify whether the effect is specific for certain
subsites and whether it reflects an association with pre-existent gallstones.
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Cancers of the biliary tract (CBT) encompass malignant
tumours arising from the gallbladder, extrahepatic bile ducts
and ampulla of Vater. These tumours are relatively uncom-
mon, accounting for less than 1% of all incident cancers in
the US (Ries et al., 1994). Because of their rarity, risk factors
have not been well examined. However, an association with
antecedent gallstones is clearly established (Diehl, 1983;
Lowenfels et al., 1985; Maringhini et al., 1987), along with
obesity and high parity among women (Yen et al., 1987;
Zatonski et al., 1992; Chow et al., 1994; Moerman et al.,
1994a). An increased risk of CBT has been associated with
cigarette smoking in a few recent case-control studies
(Ghadirian et al., 1993; Chow et al., 1994; Moerman et al.,
1994b), but not in another study ofcancer ofthe extrahepatic
bile duct (Yen et al., 1987). To examine further the role of
cigarette smoking on CBT risk, we evaluated CBT mortality
in a cohort of US veterans followed for up to 26 years.
smokers are based solely on information obtained in 1954/
1957.
Included in the analysis were 248 046 veterans (84% of the
cohort) who responded to the questionnaires. The mortality
of cohort members was ascertained until September 30, 1980,
with about 96% completeness of ascertainment. Death
certificates were obtained for 95% of the deceased veterans.
Causes of death were coded using the Seventh Revision of
the International Statistical Classification of Diseases (ICD7)
(WHO, 1957). In earlier reports on this cohort, CBT (ICD7
code 155.1) was not examined separately (Dorn, 1959; Kahn,
1966; Rogot and Murray, 1980). In the present analysis, the
associations between CBT and tobacco use were assessed by
relative risks (RRs) and corresponding 95% confidence inter-
vals (CIs), using a Poisson regression program for modelling
hazard functions with grouped data (Preston et al., 1985).
RRs were adjusted for age and calendar time periods in 5
year intervals.
Materials and methods
Details of the cohort and methods of follow-up have been
reported elsewhere (Dorn, 1959; Kahn, 1966; Rogot and
Murray, 1980; McLaughlin et al., 1990). Briefly, the cohort
comprised over 290 thousand US veterans who served in the
Armed Forces between 1917 and 1940, and held active US
Government life insurance policies in 1953. Over 99.5% of
policy holders were men, and nearly all were white. Inform-
ation on tobacco use, including current and past smoking
status, type of tobacco used, amount of current tobacco use,
and age at starting to smoke, was obtained from mailed
questionnaires in 1954, and in 1957 for non-respondents to
the first mailings. Duration of smoking was estimated by the
difference between age at 1954 or 1957 and age started
smoking. No additional information on tobacco use has been
collected since the initial mailings; hence, categories of
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Results
A total of 303 CBT deaths among cohort respondents was
reported during the study period. Current smokers (in 1954
or 1957) had a significant 50% excess risk ofCBT (RR = 1.5,
CI= 1.1-2.0) compared with those who had never used any
tobacco (Table I). In addition, non-significant excess risks
were observed among former cigarette smokers (RR = 1.2,
CI = 0.8-1.8), smokers of pipes/cigars only (RR = 1.4,
CI = 0.9-2.2), and 'other' smokers (RR = 1.4, CI = 0.9-2.0),
most of whom were former cigarette smokers who currently
smoked cigars/pipes (Table I).
Among current cigarette smokers, a nearly 2-fold risk of
CBT (RR = 1.8, CI= 1.2-2.7) was associated with smoking
more than 20 cigarettes per day, although the dose-response
trend (P<0.05) with amount of cigarette consumption was
not smooth (Table II). After adjustment for age, calendar
time period, and number of cigarettes smoked per day, a
consistent inverse association was found with age at starting
smoking (P<0.05). Risk increased from 1.4 (CI= 0.8-2.7)
among those who started smoking at age 25 or older to 1.8
(CI= 1.1-3.1) among those who started under age 20. No
clear association with duration of smoking was observed.Smoking and biliary tract cancers
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Table I Relative risks (RRs) and 95% confidence intervals (CIs) of biliary tract
cancers and tobacco use among US veterans, 1954-80
Number Person-
Smoking categories ofdeaths years RRa 95% CI
Total number of cases 303
Never any tobacco 60 1 064 337 1.0 -
Cigars/pipes only 35 407 625 1.4 0.9-2.2
Other smokersb 51 658 478 1.4 0.9-2.0
Former cigarette smokers 49 743 281 1.2 0.8-1.8
Current cigarette smokersc 108 1 657 270 1.5 1.1-2.0
aAdjusted forageandcalendartimeperiod.bSmokerswhodid notfitinto one ofthe
other categories, mostly formercigarette smokers who currently smoked cigars/pipes.
cIncluded cigarette smokers who also used cigars or pipes.
Table II Relative risks (RRs) and 95% confidence intervals (CIs) ofbiliary tract cancers
inrelation toamountanddurationofsmokingandageatstarting smokingamongcurrent
smokers
Number Person-
Smoking variables ofdeaths years RR 95% CI
Never any tobacco 60 1 064 337 1.0 -
Number of cigarettes per day'
<10 21 238 834 1.6 1.0-2.6
10-20 45 834 010 1.2 0.8-1.8
21 + 42 584423 1.8 1.2-2.7
Age at starting smoking (years)b
<20 58 930 203 1.8 1.1-3.1
20-24 32 474 893 1.6 0.9-2.9
>24 18 243 276 1.4 0.8-2.7
Duration of smoking (years)b
<30 16 569 418 1.6 0.8-3.3
30-39 41 544 485 1.7 0.9-2.9
40 + 51 534 483 1.7 1.0-2.9
aRR adjusted for age and calendar time period. bRR adjusted for age, calendar time
period, and number of cigarettes smoked per day.
Discussion
The relation of tobacco smoking to CBT has been examined
in a few small case-control studies. Among the findings are
an excess risk of CBT among smokers who did not drink
alcohol (Moerman et al., 1994b), a 3-fold risk of extrahepatic
bile duct cancers among heavy smokers (Chow et al., 1994), a
small excess risk of gallbladder cancer and a nearly 3-fold
risk of extrahepatic bile duct cancer among smokers of non-
filtered cigarettes (Ghadirian et al., 1993). However, an
inverse association between cigarette smoking and risk of
CBT was reported in an earlier hospital-based study (Yen et
al., 1987), in which controls might be more likely to have
smoked than the general population.
In this attempt to examine the association between tobacco
use and CBT employing a cohort study design, we found a
small excess risk among cigarette smokers and a suggestive
dose-response relationship with amount of smoking and age
started smoking. Our results provide further evidence linking
smoking and CBT, although the risk estimates are lower than
those reported in recent case-control studies (Ghadirian et
al., 1993; Chow et al., 1994; Moerman et al., 1994b).
A limitation of our study is that information on smoking
habits was available only for 1954/1957. If the smoking
patterns in this cohort of veterans resemble those of
American men in general, over 40% of those smoking then
may have stopped smoking during the 26 years of follow-up
(US Surgeon General, 1989). Therefore, the risks of CBT
associated with cigarette smoking may be underestimated in
our study, as a result of the misclassification of ex-smokers as
current smokers. The misclassification in duration of smok-
ing also may have precluded the detection of a
dose-response relation with risks.
Another limitation is that medical records were not
obtained for cases in this study. However, in a previous study
conducted to examine the accuracy of US cancer mortality
data, 86.5% of CBT reported on death certificates was
confirmed by hospital records (Percy et al., 1981). In addi-
tion, we could not evaluate risk of CBT by anatomic subsite
since these tumours were not coded separately in ICD7, so
more detailed studies are needed. It is also important to
evaluate information on other risk factors, including gall-
stones, which have been linked to smoking in some studies
(McMichael et al., 1992; Grodstein et al., 1994). Excess
gallstone risks of 30% to 2-fold have been observed among
smokers, particularly among women (Baron and Logan,
1990; McMichael et al., 1992; Grodstein et al., 1994). Future
studies should examine whether smoking affects CBT risks
directly by a carcinogenic effect or indirectly by an associa-
tion with gallstones.
In summary, this cohort study suggests that cigarette
smoking is a weak risk factor for CBT. Additional studies of
CBT are needed to clarify the effects of smoking on subsites
of the biliary tract and to identify the mechanisms by which
smoking may be related to CBT.
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